Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Neumora Therapeutics, Inc. | Chief Strategy Officer | Common Stock | 115K | $1.31M | $11.39 | Sep 12, 2024 | Indirect |
Neumora Therapeutics, Inc. | Chief Strategy Officer | Common Stock | 97.5K | $1.11M | $11.39 | Sep 12, 2024 | Direct |
Neumora Therapeutics, Inc. | Chief Strategy Officer | Stock Option (Right to Buy) | 72.2K | Sep 12, 2024 | Direct | ||
Neumora Therapeutics, Inc. | Chief Strategy Officer | Stock Option (Right to Buy) | 29.7K | Sep 12, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NMRA | Neumora Therapeutics, Inc. | Sep 12, 2024 | 6 | $0 | 4 | Sep 13, 2024 | Chief Strategy Officer |
NMRA | Neumora Therapeutics, Inc. | Apr 22, 2024 | 1 | $0 | 4 | Apr 24, 2024 | Chief Strategy Officer |
NMRA | Neumora Therapeutics, Inc. | Feb 14, 2024 | 2 | $0 | 4 | Feb 16, 2024 | Chief Strategy Officer |
NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 0 | $0 | 3 | Sep 14, 2023 | Chief Strategy Officer |